Measurement of the acute inflammatory response to walking exercise in COPD: effects of pulmonary rehabilitation by Canavan, Jane et al.
© 2007 Dove Medical Press Limited.   All rights reserved
International Journal of COPD 2007:2(3) 347–353 347
ORIGINAL RESEARCH
Measurement of the acute inﬂ  ammatory 
response to walking exercise in COPD: effects 
of pulmonary rehabilitation
Jane Canavan1
Rachel Garrod1
Johanna Marshall1
David Jackson1
Paula Ansley2
Andy Jewell3
1School of Physiotherapy, Faculty 
of Health and Social Care Sciences, 
St. George’s, University of 
London, London, United Kingdom; 
2Department of Sport and Exercise 
Science, Institute of Biomedical and 
Biomolecular Sciences, University 
of Portsmouth, Portsmouth, United 
Kingdom; 3Radiography, Faculty 
of Health and Social Sciences, St. 
George’s, University of London, 
London, United Kingdom
Objective: This pilot study concerns the evaluation of the acute cytokine response to exercise 
and changes in this throughout a 7 week pulmonary rehabilitation programme.
Methods: 17 (10 male, 7 female) stable COPD patients, mean (SD) age 69 (8) yrs, mean FEV1, 
51.3 (17.3) % predicted entered into 7 weeks of rehabilitation. The acute cytokine response 
(ACR) was measured from serum cytokine levels; Interleukin-6 (IL-6), tumor necrosis factor-α 
(TNF-α) and C-reactive protein (CRP) taken pre, post and 1 hour post-maximal incremental 
shuttle walking test (ISWT). The ACR to maximal exercise was determined before rehabilita-
tion (T0) and post rehabilitation (T7). The ACR (pre/post test) to iso-distance exercise (based 
on initial ISWT distance) was determined throughout the rehabilitation period at 2 (T2), 4 (T4) 
weeks and at the end (T7).
Results: 12 patients completed the study. Maximal ISWT distance signiﬁ  cantly increased 
after rehabilitation. There was no signiﬁ  cant change in baseline cytokine level throughout; or 
in pre/post-exercise cytokine levels prior to, during or following rehabilitation.
Conclusions: There was no signiﬁ  cant inﬂ  ammatory response associated with maximal exercise 
before or after training. Cytokine responses to a ﬁ  xed bout of exercise did not alter markedly 
throughout. Clinical PR is unlikely to exacerbate systemic inﬂ  ammation in COPD.
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Introduction
Chronic obstructive pulmonary disease (COPD) is characterized by ﬁ  xed airﬂ  ow 
obstruction and systemic inﬂ  ammatory complications. Serum inﬂ  ammatory markers 
are elevated in patients with COPD compared with healthy subjects (Gan et al 2004) 
and catabolic and anabolic imbalances may have deleterious effects on peripheral 
muscle (Debigare et al 2001). There is increasing evidence to support the premise 
that inﬂ  ammation may contribute to impairment in health status and exercise toler-
ance in patients with COPD (Broekhuizen et al 2006). Exercise as part of pulmonary 
rehabilitation is a proven beneﬁ  cial therapy for COPD, improving symptoms and 
functional outcomes (Lacasse et al 2002). In healthy individuals strenuous exercise 
has been shown to provoke an inﬂ  ammatory response with predominant production 
of anti-inﬂ  ammatory cytokines interleukin-6 (IL-6), interleukin-1 receptor agonist 
(IL-1ra) and soluble-tissue necrosis factor receptors (s-TNF-R) (Petersen and Peder-
sen 2005), whilst pro-inﬂ  ammatory IL-6 may help to attenuate production of TNF-α 
(Starkie et al 2003).
Since COPD patients demonstrate increased systemic inﬂ  ammation at rest (van 
Helvoort et al 2005), it is theorized that exercise should be carefully prescribed to avoid 
intensifying the inﬂ  ammatory state. Early data shows higher TNF-α and IL-6 in CF 
patients compared with healthy subjects. These differences persisted after moderate 
Correspondence: Jane L Canavan 
School of Physiotherapy, Faculty of Health 
and Social Care Sciences, St. George’s, 
University of London, Cranmer Terrace, 
London SW17 0RE, United Kingdom
Tel +44 208 266 6193 
Fax +44 208 725 2248 
Email p0500319@sgul.ac.ukInternational Journal of COPD 2007:2(3) 348
Canavan et al
intensity exercise (Tirakitsoontorn et al 2001). Similarly, 
COPD patients are de-conditioned and exercise might induce 
a larger increase in these inﬂ  ammatory mediators. Rabinov-
ich et al demonstrated a signiﬁ  cant increase in TNF-α after 
11 minutes of constant work rate cycling exercise in severe 
COPD patients but not in healthy subjects (Rabinovich et 
al 2003). Individual cytokine response varies greatly, with 
intensity and duration of exercise (Petersen and Pedersen 
2005) body composition (Schols et al 1996), age and gender 
(Timmons et al 2006).
The paucity of research available regarding the acute 
exercise-induced cytokine response in COPD patients makes 
inferring relationships difﬁ  cult. A signiﬁ  cant reduction in 
baseline CRP has been demonstrated in healthy marathon run-
ners after 9 months of training compared to untrained controls 
(Mattusch et al 2000). Greiwe and colleagues reported that 
following 6 months of resistance training, healthy older sub-
jects had reduced muscle TNF-α, mRNA and protein levels 
whilst anabolism increased (Greiwe et al 2001). Exercise in 
healthy subjects clearly confers anti-inﬂ  ammatory beneﬁ  ts, but 
whether this also occurs in COPD, is at present unknown.
The purpose of this pilot study was to determine the 
cytokine response to a maximal walking test, and to determine 
whether there was any effect of a 7-week training and educa-
tion programme on the response to ﬁ  xed walking exercise.
Methods
Patients
Twenty patients with a known diagnosis of COPD were 
recruited through primary and secondary referral processes. 
COPD was conﬁ  rmed with spirometry values consistent with 
obstructive airways disease (The COPD guidelines group of 
the standards of care committee of the british thoracic society 
1999). Seventeen (10 males, 7 females) COPD patients 
(aged 55–82 years) with mild to very severe COPD (FEV1 
94%–27% predicted) according to GOLD criteria (Buist 
et al 2006), attended for an initial assessment. Six patients 
were present smokers, 10 patients were ex-smokers and 1 
patient was described as a non-smoker, mean (SD) pack 
years 48.1 (17.8). Twelve (6 male, 6 female) COPD patients 
(aged 62–82 years) with mild to very severe COPD (FEV1 
91%–22% predicted) according to GOLD criteria (Buist et 
al 2006) completed pulmonary rehabilitation and the testing 
protocol. 3 patients were still smoking, 8 were ex-smokers, 
and 1 patient was described as a non-smoker. Exclusion 
criteria consisted of exacerbation necessitating any change 
in medication or signiﬁ  cant worsening of symptoms within 
the 6 weeks prior to the ﬁ  rst assessment, unstable angina or 
known cardiac disease, mobility limiting joint problems, 
known neurological disease and other inﬂ  ammatory condi-
tions such as rheumatoid arthritis. Medication was unaltered; 
no patients were receiving oral steroids at the time of the 
study. Full ethical approval was received from Merton & 
Sutton/Wandsworth COREC and patients gave informed 
written consent.
Primary outcomes
Exercise capacity was assessed using the incremental 
shuttle walk test (ISWT) which is a maximal, standardised, 
externally paced incremental exercise test (Singh et al 1992). 
The test involves the patient walking between two cones 
placed 9 meters apart (hence a distance of 10 m) at a speed 
externally paced via the use of a tape recording. The speed of 
shuttles increases each minute until the patient can no longer 
match the pace or reaches a symptom limiting maximum. 
The instructions are standardised and delivered via the tape 
recording. One practice walk was performed a week prior to 
the ISWT. For safety reasons percutaneous oxygen saturation 
(SpO2) and heart rate (HR) were monitored throughout the 
test and patients were stopped if blood oxygen saturation fell 
to less than 80% or predicted HR max was reached.
Acute exercise induced cytokine 
response
The acute exercise induced cytokine response was measured 
from venous blood collected from the cubital veins before 
ISWT and immediately post ISWT (T0). A further blood 
sample was taken after patients rested for 1 hour. Patients 
then entered a 7 week pulmonary rehabilitation programme. 
Pre and post ISWT blood tests were repeated using the iso-
distance measurements of ISWT (patients were instructed to 
stop at the level achieved at the initial assessment ISWT) at, 
2 weeks (T2) and 4 weeks (T4) into the training period and 
at 7 weeks (T7), the end of the rehabilitation period.
After rehabilitation (T7) two walking tests were per-
formed 2 days apart: a symptom-limited maximal ISWT and 
an iso-distance measurement based on the results of the initial 
walking test. The acute cytokine response was determined for 
both these walks. At T0 and T7 patients were asked to rest 
after the walking tests for 1 hour and bloods were taken again 
to evaluate further post-exercise responses (Figure 1).
The rehabilitation programme
Patients attended outpatient pulmonary rehabilitation, which 
consisted of exercise and education sessions in accordance 
with BTS guidelines (Morgan et al 2001), twice weekly International Journal of COPD 2007:2(3) 349
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for 7 weeks. If sessions were missed, additional attendance 
was organized. In addition to this, patients were required 
to complete 20 minutes of home exercise each day, ﬁ  ve 
times a week. The exercise programme has been previously 
described (Garrod et al 2004). Each rehabilitation session 
comprised one hour of exercise followed by an education 
session. Exercises were a mixture of functional aerobic and 
resistance activities-walking and cycling, sit to stands, step-
ups and upper limb work.
Cytokine measurements
C-reactive protein (CRP) Interleukin 6 (IL-6) and tumor 
necrosis factor α (TNF-α) were determined from venous 
blood at the time points described above. Plasma was fro-
zen at –80 °C within an hour of sampling. High sensitivity 
CRP, IL-6 and TNF-α were all measured using commer-
cially available assays (Euro/DPC Ltd, Gwynedd, UK) and 
performed on an Immulite® automated analyser (Euro/DPC 
Ltd). The functional sensitivities of each of the assays were 
0.2 mg/L–1, 2.0 pg/mL–1, and 1.7 pg/mL–1 for CRP, IL-6 
and TNF-α respectively. The manufacturer claimed within-
assay and between-assay precisions to be less than 8% at the 
concentrations reported here for all three assays.
Spirometry
Spirometry was performed using a hand held Spirometer 
(Microloop ML 3535, Micromedical Ltd.,). The best of 3 
attempts was taken and all researchers were trained in the 
use of spirometry according to American Thoracic Society 
guidelines (The COPD guidelines group of the standards of 
care committee of the British Thoracic Society 1999). Verbal 
encouragement was standardized for all tests.
Body composition
Percentage body fat was determined using bioelectrical-
impedance methods with Tanita scales (Body Composition 
Analyzer, BC-418MA, Tanita, UK Ltd, The Barn, Philpots 
Close, Yiewsley, West Drayton, Middlesex, England, 
UB77RY). Fat mass was calculated using body fat percentage 
and body weight; fat free mass was calculated by subtracting 
fat mass from body weight. FFMI was calculated by FM in 
kg/(height in m2) and nutritional depletion was deﬁ  ned as 
Prior to rehabilitation (T0) 2 weeks rehabilitation (T2) 4 weeks rehabilitation (T4) 7 weeks rehabilitation (T7)
Cytokine measurement   Cytokine measurement Cytokine measurement Cytokine measurement
     Maximal ISWT     Iso-distance ISWT  Iso-distance ISWT Iso-distance ISWT
Cytokine measurement                            Cytokine measurement            Cytokine measurement              Cytokine measurement
1 hour 
Cytokine measurement 
Cytokine measurement
     Maximal ISWT
Cytokine measurement
1 hour 
Cytokine measurement
Figure 1 Schematic diagram depicting cytokine measurements and walking tests during pulmonary rehabilitation.International Journal of COPD 2007:2(3) 350
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BMI 21 kg.m2 and/or FFMI 15 (females) or 16 (males) 
kg.m2 (Schols et al 1993).
Quadriceps muscle strength
Quadriceps muscle strength was tested using a hand held 
Myometer (SH-5001, Physio-Med Services, Glossop Brook 
Business Park, Surrey Street, Glossop, Derby, SK13 7AJ) 
with the patient seated and knee at 90° ﬂ  exion.
Health status
Health status was assessed using the St. George’s Respira-
tory Questionnaire (SGRQ) (Jones et al 1992). This 50 item, 
disease-speciﬁ  c, self-complete questionnaire has been vali-
dated to measure health impairment in respiratory patients. 
Scores range from 100 ‘worst possible health status’ to 0 
‘best possible health status.’
Statistical analysis
Pre-exercise TNF-α data at T4 from 1 subject was removed 
as this subject had an abnormally high result, which was 
signiﬁ  cantly lower at all other time points. The acute exercise 
induced cytokine response to a ﬁ  xed bout of exercise (iso-
ISWT) throughout the pulmonary rehabilitation programme 
was calculated by: rest cytokine value-post walk value for T0, 
T2, T4, T7 and analysis of variance (ANOVA) was used to 
identify change in this response. These data were normally 
distributed. Paired t tests were used to identify change in 
cytokine response to the maximal walking test before and 
after pulmonary rehabilitation. To identify differences in the 
plasma level of CRP, IL-6 and TNF- at rest, post and 1 hour 
post-maximal ISWT at T0 and T7, Friedman’s test was used 
(cytokine data was not normally distributed). Heterogeneity 
in the acute cytokine response at T0 was explored according 
to the acute cytokine response. Baseline characteristics for 
those that dropped out of rehabilitation were compared with 
those that completed using Mann Whitney un-paired test.
Results
Patient details
Baseline characteristics (Table 1) of the patients who com-
pleted rehabilitation (n = 12) compared to those who did not 
(n = 5) were not signiﬁ  cantly different apart from forced vital 
capacity (FVC) mean difference (95% CI) 1.7 (0.43 to 3.04)l 
and shuttle walk distance mean difference (95% CI) 197.8 
(77.7 to 318.0)m. One female patient suffered from fat free 
mass depletion (FFMI 13.8kg.m2) and nutritional depletion 
(BMI 14.5 kg.m2). This female had a reduced CRP and IL-6 
concentration pre and post exercise at T0 compared with the 
non-depleted group value (median (range) CRP pre: 0.82 vs 
3.88 (12.34); CRP post: 0.51 vs 4.2 (13.0); IL-6 pre: 2.1 vs 
2.3 (5.0); IL-6 post: 2.1 vs 3.2 (4.3)), whilst at T0, TNF-α pre 
exercise was similar but post exercise higher (TNF- α pre: 
15.0 vs 6.8 (43.2); TNF-α post: 33.0 vs 6.8 (43.2)).
Effects of rehabilitation
As expected there was a statistically signiﬁ  cant effect of 
rehabilitation on maximal ISWT, mean difference (95% 
CI) 37.5 (10.4 to 64.6) m, although it is not clear how much 
of an improvement in distance is needed to be clinically 
signiﬁ  cant (The Australian lung foundation and Australian 
physiotherapy association 2006). However, Quadriceps 
strength did not change signiﬁ  cantly over time (p = 0.24) 
n/kg, nor did SGRQ Scores (p = 0.43).
Iso-distance cytokine response
Table 2 shows the exercise induced cytokine response at 
equivalent work load (iso time ISWT) over 7 week rehabilita-
tion period (n = 12). There were no signiﬁ  cant differences 
over time. 8 patients were able to complete iso time ISWT’s 
over the 7 week training period, whilst 3 patients were not 
able to complete this distance at all times: patient 7 had a 
reduction of 20 m at 2 and 4 weeks; patient ‘s10 and 11 had 
a reduction of 20 m at week 7.
Maximal distance cytokine response
There was no signiﬁ  cant difference in the acute cytokine 
response to a maximal bout of walking pre or post rehabilita-
tion in these patients (Table 3).
One hour post
At the one hour time point after the maximal exercise test, 
before and upon completion of rehabilitation, there was no sig-
niﬁ  cant difference in CRP, IL-6 or TNF-α (data not shown).
Table 1 Patient characteristics
N  12
Male/Female 6  6
Age years  69 (8)
BMI kg.m–2 28.4  (7.2)
FEV1 L  1.4 (0.8)
FEV1 % predicted  48.9 (19.3)
FFM kg.m–2 23.2  (12.1)
FFMI kg.m–2 20.6  (3.4)
Maximal ISWT distance (m)  234.2 (92)
Data are presented as mean (SD). BMI: body mass index; FEV1: forced expiratory 
volume in one second; % predicted: per cent predicted. FFMI: fat-free mass index; 
FFM: Fat mass index; ISWT: incremental shuttle walk test. International Journal of COPD 2007:2(3) 351
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Heterogeneity in acute cytokine response
There was heterogeneity in the acute cytokine response 
to a maximal bout of walking between subjects at base-
line (Figure 2).
Dropouts compared with those that 
completed rehabilitation
Those that dropped out of rehabilitation demonstrated a 
signiﬁ  cantly higher walking distance, mean difference (SD); 
197.8(56.3) m (p = 0.05) and greater FVC; 1.7 (0.6) l 
(p = 0.01) at baseline.
Discussion
The main ﬁ  ndings of this study strongly support the view 
that in response to a maximal bout of walking in COPD 
patients there is no signiﬁ  cant acute cytokine response 
demonstrated. Although, in this pilot study our sample size 
is small, we note the large standard deviations for cytokine 
response and consistency of our results. This suggests that 
in this population of COPD patients, changes in cytokine 
levels as a result of maximal walking are likely to be small 
if present at all. This novel study design enabled us to assess 
possible change in cytokine response to iso-distance exercise 
throughout the training period. There was no modiﬁ  cation 
to cytokine levels (or acute changes) over the 7-week period 
of rehabilitation. There was however, heterogeneity in the 
exercise induced cytokine response between subjects. A 
number of factors are known to inﬂ  uence the acute exercise 
induced cytokine response including body mass composition 
(Schols et al 1996), age, gender (Timmons et al 2006), car-
bohydrate load (Nieman et al 2005) and timing of exercise in 
relation to previous bouts of activity (Li and Gleeson 2004). 
Unfortunately in this study we did not standardise for caffeine 
and carbohydrate ingestion prior to testing. We did how-
ever record body composition prior to the testing procedure 
but there was no signiﬁ  cant difference in cytokine release 
according to percentage body fat. In one female patient, with 
lean mass and nutritional depletion, TNF-α release after the 
initial exercise bout was high, compared with the rest of 
the group who were not depleted. This ﬁ  nding is similar to 
that of other authors suggesting that muscle status may be 
an important determinant in the inﬂ  ammatory response to 
exercise (Rabinovich et al 2003; van Helvoort et al 2005; 
van Helvoort et al 2006).
Detailed characterisation of patients prior to these 
evaluations will be necessary in order to enable us to even-
tually tease out possible inﬂ  uences on cytokine exercise 
responses.
In accordance with us, Rabinovich and colleagues 
recently showed that IL-6 levels remained unchanged in 
both 6 healthy subjects and 11 COPD patients after exer-
cise (Rabinovich et al 2003). In this study steady state low 
intensity exercise (40% of maximal) was chosen as the 
stimulus and sustained for 11 minutes. However, interest-
ingly, TNF-α levels increased signiﬁ  cantly from baseline in 
Table 2 Exercise induced cytokine response at equivalent work load (iso distance ISWT) over 7 week rehabilitation period (n = 12)
  CRP pre ISWT  CRP post ISWT  IL6 pre ISWT  IL6 post ISWT  TNF pre ISWT  TNF post ISWT
   (mg/l)    (mg/l)   (pg/ml)   (pg/ml)   (pg/ml)   (pg/ml)
Week 1  3.8 (12.4)  3.5 (13.1)  2.2 (5.0)  2.6 (1.5)  8.7 (43.2)  7.7 (40.0)
Week 2  2.3 (9.7)  2.8 (10.1)  3.1 (4.9)  2.9 (4.5)  8.4 (31.6)  9.1 (35.8)
Week 4  2.4 (7.6)  2.4 (10.2)  3.6 (4.1)  3.4 (6.5)  8.9 (37.6)  10.0 (36.3)
Week 7  2.6 (9.9)  3.4 (13.1)  3.5 (5.7)  3.9 (6.7)  10.2 (43.0)  9.6 (56.6)
Data presented as median (range)
Table 3  Acute exercise induced cytokine response (before and after bout of walking) pre and post 7 week rehabilitation period
  Pre rehabilitation  Post rehabilitation  Mean diff (95% CI)  P value
Δ TNF (n = 10)  3.6 (13.9)  −1.1 (15.5)  −1.1 (−3.7 to 1.5)  0.5
 (pg/ml)
Δ CRP (n = 12)  0.2 (2.1)  1.2 (2.7)  −0.5 (−1.7 to 0.7)  0.4
 (mg/l)
Δ IL6 (n = 11)  −0.2 (1.0)  0.3 (1.5)  4.6 (−11.3 to 20.6)  0.4
 (pg/ml)
Mean change calculated resting cytokine – post walk cytokine measure – negative value = rise in cytokine expression
All change data showed normal distributionInternational Journal of COPD 2007:2(3) 352
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the COPD patients, even persisting after 8 weeks training, 
but did not in the healthy controls (Rabinovich et al 2003). 
We had hypothesised, that as in healthy subjects, IL-6 would 
prove to attenuate exercise induced TNF-α levels (Starkie 
et al 2003). However, we found little evidence of this in our 
study. Body composition was not assessed by Rabinovich 
and colleagues making comparison with their study difﬁ  cult. 
It is feasible that in their study the population were depleted 
(Rabinovich et al 2003).
Van Helvoort in contrast, tested 16 COPD subjects with 
maximal incremental cycle ergometry and although circu-
lating lymphocytes were signiﬁ  cantly higher after exercise, 
there were no changes in CRP; whilst IL-6 and TNF-α were 
not measured (van Helvoort et al 2005). At present we cannot 
tell whether the exercise induced cytokine response in COPD 
differs from that of healthy subjects or whether it is merely a 
reﬂ  ection of the fact that by necessity exercise intensities are 
considerably lower. A criticism of our study is that, unlike 
these previous studies, we did not include healthy control 
subjects; we were however predominantly interested in any 
modifying effects of rehabilitation in this group rather than 
comparisons.
These data support the now well established view that sys-
temic inﬂ  ammation is higher in patients with COPD (Gan et al 
2004) particularly in muscle-wasted COPD patients, and that 
acute maximal exercise in non-muscle wasted COPD patients 
does not cause pronounced cytokine release (van Helvoort 
et al 2006). There is strong evidence in healthy subjects that 
CRP levels of higher that 3 mg/L–1 are highly associated with 
cardiovascular mortality and morbidity (Torres and Ridker 
2003). Our hypothesis, that pulmonary rehabilitation may 
modify pro-inﬂ  ammatory mediators, as long term training 
in healthy subjects does (Jankord 2004), has not been dem-
onstrated in this small pilot study. Five out of our 17 patients 
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Figure 2 Individual changes (pre-post) in interleukin-6, tumour necrosis factor alpha and C-reactive protein with maximal incremental shuttle walking test before 
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were unable to complete rehabilitation, (4 patients suffered 
an exacerbation and 1 refused after initial assessment). Our 
patients who dropped out of rehabilitation were able to walk 
signiﬁ  cantly further than those who completed rehabilitation. 
This limits our study ﬁ  ndings since these may be ﬁ  tter patients 
who might have been expected to train at a higher intensity and 
endurance and therefore show a modifying effect of exercise 
on inﬂ  ammatory markers. Thus before we conclude a lack of 
effect of training on inﬂ  ammation in COPD subjects, further 
trials would do well to look at longer term training, possibly 
with increased resistive exercise (Greiwe et al 2001) in patents 
with mild disease and in larger samples. In conclusion, this 
study is reassuring in that clinical pulmonary rehabilitation 
is unlikely to enhance systemic inﬂ  ammation in non-muscle 
wasted COPD patients.
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